Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study ; volume:18 ; number:1 ; day:25 ; month:11 ; year:2017 ; pages:1-8 ; date:12.2017
BMC nephrology ; 18, Heft 1 (25.11.2017), 1-8, 12.2017
- Schlagwort
-
Urologische Chirurgie
- Urheber
-
Louw, Elizabeth Helene
- Beteiligte Personen und Organisationen
-
Chothia, Mogamat-Yazied
SpringerLink (Online service)
- DOI
-
10.1186/s12882-017-0752-x
- URN
-
urn:nbn:de:1111-2018013114016
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Louw, Elizabeth Helene
- Chothia, Mogamat-Yazied
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia
Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients
Effect of erythropoietin-stimulating agent on uremic inflammation
Positive association of residual kidney function with hemoglobin level in patients on peritoneal dialysis independent of endogenous erythropoietin concentration
Erythropoietin regulates developmental myelination in the brain stimulating postnatal oligodendrocyte maturation
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?
Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors
Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
Effectiveness of binocularity-stimulating treatment in children with residual amblyopia following occlusion
Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia
Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients
Effect of erythropoietin-stimulating agent on uremic inflammation
Positive association of residual kidney function with hemoglobin level in patients on peritoneal dialysis independent of endogenous erythropoietin concentration
Erythropoietin regulates developmental myelination in the brain stimulating postnatal oligodendrocyte maturation
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?
Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors
Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
Effectiveness of binocularity-stimulating treatment in children with residual amblyopia following occlusion
Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia
Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients
Effect of erythropoietin-stimulating agent on uremic inflammation
Positive association of residual kidney function with hemoglobin level in patients on peritoneal dialysis independent of endogenous erythropoietin concentration
Erythropoietin regulates developmental myelination in the brain stimulating postnatal oligodendrocyte maturation
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?
Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors
Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients